G1 Therapeutics Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	21.1	25.36	9.52	10.89
Depreciation & Amortization	9.2	6.27	4.33	1.58
Loss (Gain) From Sale of Assets	-2.51	-2.4	-0.06	0.21
Loss (Gain) From Sale of Investments	-	-0.08	-0.55	-0.23
Loss (Gain) on Equity Investments	-	-	0.22	-
Provision & Write-off of Bad Debts	-	0.09	0.18	-
Other Operating Activities	4.7	3.56	0.37	2.24
Change in Accounts Receivable	-16.88	-75.19	7.63	-5.74
Change in Inventory	0.73	0.31	0.98	-1.27
Change in Accounts Payable	3.47	9.9	0.79	1.65
Change in Unearned Revenue	-13.73	24.17	-1.59	-
Change in Other Net Operating Assets	-16.08	9.59	-8.29	-5.19
Operating Cash Flow	-10	1.59	14.06	4.14
Operating Cash Flow Growth	-	-88.71%	239.89%	-
Capital Expenditures	-6.28	-12.86	-12.48	-4.04
Sale of Property, Plant & Equipment	0.02	4.02	0.06	0.23
Sale (Purchase) of Intangibles	-0.26	-0.12	-	-
Sale (Purchase) of Real Estate	6.3	-	-4.09	-
Investment in Securities	-	1.17	-1.09	0.39
Investing Cash Flow	-0.22	-7.8	-17.59	-3.42
Short-Term Debt Issued	-	-	-	19.41
Long-Term Debt Issued	158.89	41.44	73.25	6.8
Total Debt Issued	158.89	41.44	73.25	26.21
Short-Term Debt Repaid	-	-	-	-19.92
Long-Term Debt Repaid	-120.96	-41.78	-58.02	-8.8
Total Debt Repaid	-120.96	-41.78	-58.02	-28.72
Net Debt Issued (Repaid)	37.93	-0.34	15.23	-2.5
Common Dividends Paid	-2	-3.01	-4	-
Financing Cash Flow	35.93	-3.35	11.23	-2.5
Miscellaneous Cash Flow Adjustments	-	-	-0.63	-
Net Cash Flow	25.71	-9.55	7.06	-1.79
Free Cash Flow	-16.28	-11.27	1.57	0.1
Free Cash Flow Growth	-	-	1509.10%	-
Free Cash Flow Margin	-5.09%	-4.33%	1.28%	0.08%
Free Cash Flow Per Share	-3.88	-2.68	0.38	-
Cash Interest Paid	8.14	4.82	2.07	-
Levered Free Cash Flow	-23.42	-20.14	5.68	-
Unlevered Free Cash Flow	-17.25	-16.79	7.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.